norepinephrine/dopamine/serotonin reuptake inhibitors (Neuroventi)

N/A

Report date: 2025/06/11 11:04:06
NME

Base Information

Drug Namenorepinephrine/dopamine/serotonin reuptake inhibitors (Neuroventi)
Drug Alias NameNV-90-001NV-90-002NV-90-003
ClassificationSmall molecules
Mechanisms of ActionNorepinephrine reuptake inhibitorsCNS modulatorsDopamine uptake inhibitors +[5] 
TargetsSerotonin transporterNorepinephrine transporter
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuroVenti Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuroVenti Inc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A